HIV antiretroviral therapy costs in the United States, 2012-2018
JAMA Feb 13, 2020
McCann NC, et al. - Researchers intended to identify costs of recommended initial antiretroviral treatment (ART) regimens in the United States between 2012 and 2018 and the magnitude of cost changes over time. Compared with all other well-resourced countries, including Britain, Australia, and Canada, the United States has the highest ART prices yet the lowest rate of HIV viral suppression (54%). In the United States, high ART costs are among many structural obstacles that lead to poor treatment access and adherence, contributing to suboptimal HIV results.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries